Abstract
The size and relatively high GC content of cDNAs are challenges for efficient targeted engineering of large collagens. There are both basic biological and therapeutic interests in the ability to modify collagens, as this would allow for studies precisely describing interactions of collagens with specific interaction partners, addressing consequences of individual disease-causing mutations, and assessing therapeutic applicability of precision medicine approaches. Using collagen VII as an example, we will here describe a strategy for rapid and simple modification of cDNAs encoding large collagens. The method is flexible and can be used for the creation of point mutations, small or large deletions, and insertion of DNA.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Phillips CL, Lever LW, Pinnell SR et al (1991) Construction of a full-length murine pro alpha 2(I) collagen cDNA by the polymerase chain reaction. J Invest Dermatol 97:980–984
Bornert O, Kühl T, Bremer J et al (2016) Analysis of the functional consequences of targeted exon deletion in COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapy. Mol Ther J Am Soc Gene Ther 24:1302–1311. https://doi.org/10.1038/mt.2016.92
Chmel N, Bornert O, Hausser I et al (2018) Large deletions targeting the triple-helical domain of collagen VII Lead to mild Acral dominant dystrophic Epidermolysis Bullosa. J Invest Dermatol 138:987–991. https://doi.org/10.1016/j.jid.2017.11.014
Nyström A, Bornert O, Kühl T et al (2018) Impaired lymphoid extracellular matrix impedes antibacterial immunity in epidermolysis bullosa. Proc Natl Acad Sci U S A 115:E705–E714. https://doi.org/10.1073/pnas.1709111115
Chen M, Costa FK, Lindvay CR et al (2002) The recombinant expression of full-length type VII collagen and characterization of molecular mechanisms underlying dystrophic epidermolysis bullosa. J Biol Chem 277:2118–2124. https://doi.org/10.1074/jbc.M108779200
Nyström A, Bruckner-Tuderman L, Kern JS (2013) Cell- and protein-based therapy approaches for epidermolysis bullosa. Methods Mol Biol Clifton NJ 961:425–440. https://doi.org/10.1007/978-1-62703-227-8_29
Fritsch A, Spassov S, Elfert S et al (2009) Dominant-negative effects of COL7A1 mutations can be rescued by controlled overexpression of normal collagen VII. J Biol Chem 284:30248–30256. https://doi.org/10.1074/jbc.M109.045294
Gibson DG (2011) Enzymatic assembly of overlapping DNA fragments. Methods Enzymol 498:349–361. https://doi.org/10.1016/B978-0-12-385120-8.00015-2
Gibson DG, Young L, Chuang R-Y et al (2009) Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods 6:343–345. https://doi.org/10.1038/nmeth.1318
Ricard-Blum S (2011) The collagen family. Cold Spring Harb Perspect Biol 3:a004978. https://doi.org/10.1101/cshperspect.a004978
Varki R, Sadowski S, Uitto J, Pfendner E (2007) Epidermolysis bullosa II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes. J Med Genet 44:181–192. https://doi.org/10.1136/jmg.2006.045302
Chen M, Keene DR, Costa FK et al (2001) The carboxyl terminus of type VII collagen mediates antiparallel dimer formation and constitutes a new antigenic epitope for epidermolysis Bullosa acquisita autoantibodies. J Biol Chem 276:21649–21655. https://doi.org/10.1074/jbc.M100180200
Rattenholl A, Pappano WN, Koch M et al (2002) Proteinases of the bone morphogenetic protein-1 family convert procollagen VII to mature anchoring fibril collagen. J Biol Chem 277:26372–26378. https://doi.org/10.1074/jbc.M203247200
Moali C, Font B, Ruggiero F et al (2005) Substrate-specific modulation of a multisubstrate proteinase. C-terminal processing of fibrillar procollagens is the only BMP-1-dependent activity to be enhanced by PCPE-1. J Biol Chem 280:24188–24194. https://doi.org/10.1074/jbc.M501486200
Nyström A, Velati D, Mittapalli VR et al (2013) Collagen VII plays a dual role in wound healing. J Clin Invest 123:3498–3509. https://doi.org/10.1172/JCI68127
Bruckner-Tuderman L (2010) Dystrophic epidermolysis bullosa: pathogenesis and clinical features. Dermatol Clin 28:107–114. https://doi.org/10.1016/j.det.2009.10.020
Nyström A, Bernasconi R, Bornert O (2018) Therapies for genetic extracellular matrix diseases of the skin. Matrix Biol 71–72:330–347. https://doi.org/10.1016/j.matbio.2017.12.010
McGrath JA, Ashton GH, Mellerio JE et al (1999) Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations. J Invest Dermatol 113:314–321. https://doi.org/10.1046/j.1523-1747.1999.00709.x
Schwieger-Briel A, Weibel L, Chmel N et al (2015) A COL7A1 variant leading to in-frame skipping of exon 15 attenuates disease severity in recessive dystrophic epidermolysis bullosa. Br J Dermatol 173:1308–1311. https://doi.org/10.1111/bjd.13945
Cserhalmi-Friedman PB, McGrath JA, Mellerio JE et al (1998) Restoration of open reading frame resulting from skipping of an exon with an internal deletion in the COL7A1 gene. Lab Investig J Tech Methods Pathol 78:1483–1492
Koga H, Hamada T, Ishii N et al (2011) Exon 87 skipping of the COL7A1 gene in dominant dystrophic epidermolysis bullosa. J Dermatol 38:489–492. https://doi.org/10.1111/j.1346-8138.2010.01008.x
Goto M, Sawamura D, Nishie W et al (2006) Targeted skipping of a single exon harboring a premature termination codon mutation: implications and potential for gene correction therapy for selective dystrophic epidermolysis bullosa patients. J Invest Dermatol 126:2614–2620. https://doi.org/10.1038/sj.jid.5700435
Wu W, Lu Z, Li F et al (2017) Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model. Proc Natl Acad Sci U S A 114:1660–1665. https://doi.org/10.1073/pnas.1614775114
Turczynski S, Titeux M, Tonasso L et al (2016) Targeted exon skipping restores type VII collagen expression and anchoring fibril formation in an in vivo RDEB model. J Invest Dermatol 136:2387–2395. https://doi.org/10.1016/j.jid.2016.07.029
Bremer J, Bornert O, Nyström A et al (2016) Antisense oligonucleotide-mediated exon skipping as a systemic therapeutic approach for recessive dystrophic Epidermolysis Bullosa. Mol Ther Nucleic Acids 5:e379. https://doi.org/10.1038/mtna.2016.87
Toh ZYC, Thandar Aung-Htut M, Pinniger G et al (2016) Deletion of Dystrophin in-frame exon 5 leads to a severe phenotype: guidance for exon skipping strategies. PLoS One 11:e0145620. https://doi.org/10.1371/journal.pone.0145620
Kühl T, Mezger M, Hausser I et al (2015) High local concentrations of intradermal MSCs restore skin integrity and facilitate wound healing in dystrophic Epidermolysis Bullosa. Mol Ther J Am Soc Gene Ther 23:1368–1379. https://doi.org/10.1038/mt.2015.58
Wullink B, Pas HH, Van der Worp RJ et al (2018) Type VII collagen in the human accommodation system: expression in Ciliary body, Zonules, and lens capsule. Invest Ophthalmol Vis Sci 59:1075–1083. https://doi.org/10.1167/iovs.17-23425
Acknowledgments
Part of the work was financed by a research collaboration with ProQR, Netherlands. AN’s research was supported by grants from the German Research Foundation, DFG (grants NY90/2-1, NY90/3-2, SFB850-B11 to AN, BR1475/12-1 to LBT), and from the Dystrophic Epidermolysis Bullosa Research Association (DEBRA) (grant Nystrom Bruckner-Tuderman 1) to AN.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Bornert, O., Nyström, A. (2019). Cloning and Mutagenesis Strategies for Large Collagens. In: Sagi, I., Afratis, N. (eds) Collagen. Methods in Molecular Biology, vol 1944. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9095-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9095-5_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9094-8
Online ISBN: 978-1-4939-9095-5
eBook Packages: Springer Protocols